Authors
Latest:
The Future of IV and Subcutaneous Therapies in OncologyPanelists discuss how subcutaneous (SubQ) and intravenous (IV) oncology therapies will continue to coexist, with patient-specific factors guiding delivery method choices, while ongoing innovation and collaboration drive the growing integration of SubQ formulations as a convenient and adaptable option in cancer care.
Latest:
Implementing Team-Based Telemedicine Workflows in Safety-Net Primary CareTelemedicine in safety-net primary care faces particular challenges. Consistent, team-based workflows can support video visit implementation and health care maintenance in telemedicine visits.
Latest:
Financial Impact of Telehealth: Rural Chief Financial Officer PerspectivesInterviews with chief financial officers of rural hospitals revealed that they perceived telehealth to have some financial advantages; however, they did not believe that telehealth improved their hospitals’ financial situations.
Latest:
Contributor: The Mental Health Crisis, How We Got Here, and Where We Go NextAddressing the mental health crisis in the United States warrants innovation in treatment and recovery, and the development of mechanisms to provide and pay for them accordingly.
Latest:
Future of Mental Health Parity Landscape Up in the Air Based on Trump Administration Actions: Ali KhawarDecisions made during the first few months of the Trump administration do not inspire confidence in Ali Khawar for further protections for parity in coverage of mental health.
Latest:
Assessing Utilization of a Marketwide Price Transparency ToolConsumers strategically used a price transparency tool by searching more often in procedure markets with provider-specific information, higher charges, and more out-of-network claims and provider competition.
Latest:
Reducing Delays in Breast Cancer Care Using an Innovative Digital Health PlatformThe use of a novel digital health platform achieved a 55% reduction in time to treatment among women with a new diagnosis of breast cancer.
Latest:
The Promising Future of Alzheimer Disease TreatmentPanelists conclude the discussion with personal insight into the promising future of Alzheimer disease treatment.
Latest:
Medication Persistence and Its Impact on Type 2 DiabetesMost newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs.
Latest:
Digital Health Implementation Among Older Adults: Health Technology Navigators’ PerspectivesHealth technology navigators share perspectives on barriers to and facilitators of digital health access for older, linguistically diverse patients in a Los Angeles safety-net system.
Latest:
Final Panelist Thoughts on the Management of Pulmonary Arterial HypertensionPanelists discuss how the future of PAH treatment looks promising with potential for disease remission through reverse remodeling agents, emphasizing the need for continued research focus on patients with other forms of pulmonary hypertension and those with significant comorbidities.
Latest:
Patient Satisfaction With Letter-Based Communication of LCS Pulmonary Nodule ResultsPatients were satisfied with receiving their lung cancer screening (LCS) pulmonary nodule results via letter and considered the amount of information provided in the letter appropriate.
Latest:
Challenges of Fracture Risk Assessment in Asian and Black WomenDifferences in bone density and FRAX fracture risk scores among Black and Asian women yield greater discordance in fracture risk estimation compared with White women.
Latest:
Association of Guideline-Concordant Care With Survival, Health Care Utilization, and Costs Among Older Women With Advanced Epithelial Ovarian CancerNon–guideline-concordant care for ovarian cancer was associated with higher all-cause and cancer-specific mortality, increased health care utilization, and increased Medicare expenditures, highlighting opportunities for improving cancer care in this vulnerable group.
Latest:
Understanding Physicians’ Work via Text Analytics on EHR Inbox MessagesThis study leverages text analytics to identify work themes managed by primary care physicians in their electronic health record (EHR) inbox messages and inform managers on workflow redesign.
Latest:
Changes in Opioid Marketing Practices After Release of the CDC GuidelinesAfter the CDC guidelines’ release, total opioid marketing spending and encounters per physician decreased, but spending per encounter subsequently increased.
Latest:
Teamwork Measure Relates to Provider Experience, Burnout, and Intent to StayA 6-item teamwork measure with good construct validity correlated with favorable provider outcomes including work experience, burnout, and intent to stay with the organization.
Latest:
CMS Practice Assessment Tool Validity for Alternative Payment ModelsUsing data from 632 primary care practices, the authors show that the CMS Practice Assessment Tool has adequate predictive validity for participation in alternative payment models.
Latest:
Antihyperglycemic Treatment Patterns for Chronic Kidney Disease and Type 2 DiabetesThis study characterized antihyperglycemic medication use after chronic kidney disease onset among patients with type 2 diabetes to uncover potential unmet needs in clinical practice.
Latest:
AJMCtv® Interviews, February 2017AJMCtv® interviews let you catch up with experts in healthcare. Topics include challenges with immuno-oncology, including the patient voice in treatment decisions, and why payers should cover genomic testing.
Latest:
Clinical and Economic Outcomes of a Collaborative Cardiology Care ProgramPatients with chronic cardiac conditions benefited from a health care program that strengthened collaboration between general practitioners and cardiology specialists in Baden-Wuerttemberg, Germany.
Latest:
Long-Term Consequences of ArrhythmiasExperts discuss the complex clinical and economic challenges of atrial fibrillation, emphasizing the need for personalized care that balances symptom management, stroke prevention, and risk factor control—while recent evidence on subclinical atrial fibrillation highlights the limitations of widespread anticoagulation, reinforcing the importance of targeted, value-based strategies for optimal outcomes.
Latest:
Defining Value Among Treatment OptionsPayer decision-makers discuss defining value among agents for unintended pregnancy, uterine fibroids, and endometriosis.
Latest:
Contributor: COVID-19 Vaccine May Not Be the Ultimate PanaceaWe should look forward to a safe, effective vaccine for coronavirus disease 2019 (COVID-19) but not expect it to be the ultimate panacea.
Latest:
Long-Term Consequences of ArrhythmiasExperts discuss the complex clinical and economic challenges of atrial fibrillation, emphasizing the need for personalized care that balances symptom management, stroke prevention, and risk factor control—while recent evidence on subclinical atrial fibrillation highlights the limitations of widespread anticoagulation, reinforcing the importance of targeted, value-based strategies for optimal outcomes.
Latest:
Patient Value Co-creation Behavior Scale Based on the DART ModelThis study aimed to develop and evaluate the psychometric properties of a scale measuring patient value co-creation behavior based on the DART (Dialogue, Access, Risk assessment, Transparency) model.
Latest:
Clinical Outcomes in Heart Failure Monitoring: A Pooled Rates AnalysisThis systematic literature review and pooled rates analysis investigated the standard of care for patients with heart failure in the US post hospital discharge.
Latest:
The Unintended Consequences of Medicare’s Wage Index Adjustment on Device-Intensive Hospital ProceduresThe authors found an association between Medicare’s wage index adjustment and the differential use of labor-intensive surgical procedures and medical device–intensive minimally invasive clinical procedures across the United States.
Latest:
NACT Use Appears to Be Increasing in Less Common Epithelial Ovarian CancersPatients with low-grade serous ovarian cancer appear to have worse survival outcomes following treatment with neoadjuvant chemotherapy (NACT).
